Author | Fred Saad, MD | OncLive

Author | Fred Saad, MD

Articles

Dr. Saad on Results of Radium-223 Trial in Prostate Cancer

March 02, 2017

Video

Fred Saad, MD, professor and chief of Urology, director of Genitourinary Oncology at the University of Montreal Hospital Centers, discusses results of a trial that investigated early use of radium-223 dichloride (Xofigo) in patients with asymptomatic metastatic castration-resistant prostate cancer.

Dr. Saad on Apalutamide Combination for Castration-Resistant Prostate Cancer

February 23, 2017

Video

Fred Saad, MD, University of Montreal Hospital Centers, discusses the safety and efficacy of the apalutamide combination for patients with metastatic castration-resistant prostate cancer.

Dr. Saad on Radium-223 for Prostate Cancer

February 22, 2017

Video

Fred Saad, MD, professor and chief of Urology, Director of Genitourinary Oncology at the University of Montreal Hospital Centers, discusses radium-223 dichloride (Xofigo) for patients with prostate cancer.

Dr. Saad on Recent Updates in Active Surveillance in Prostate Cancer

February 20, 2017

Video

Fred Saad, MD, professor and chairman of Urology, director of Genitourinary Oncology, the University of Montreal Hospital Centers, discusses recent updates in active surveillance for patients with prostate cancer.

x